Analysts change outlook on top Wall Street names, including initiations, upgrades, and downgrades. Check our analyst ratings page for details.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Piper Sandler analyst Kelsey Goodwin initiated coverage on Obsidian Therapeutics, Inc.
(NASDAQ:OBX) with an Overweight rating and announced a price target of $42.
Obsidian Therapeutics closed at $34.00 on Tuesday.
Top Wall Street analysts changed outlook on top names. See all analyst rating changes, including upgrades, downgrades and…
Top Wall Street analysts changed outlook on top names. Analyst rating changes include upgrades, downgrades, and initiations. See…
Top Wall Street analysts change outlook on top names. See analyst ratings page for changes, including…
Top Wall Street analysts changed their outlook on top names. See upgrades, downgrades & initiations on analyst ratings page.…
Wall Street analysts initiated coverage on various top stocks, including VCYT, UMAC, FISN, LTRX, and TNGX with positive ratings…
Wall Street analysts changed outlook on top names. For full changes, upgrades, downgrades and initiations, see analyst ratings…
